Matching Items (3)
Filtering by

Clear all filters

150771-Thumbnail Image.png
Description
Corporations in biomedicine hold significant power and influence, in both political and personal spheres. The decisions these companies make about ethics are critically important, as they help determine what products are developed, how they are developed, how they are promoted, and potentially even how they are regulated. In the last

Corporations in biomedicine hold significant power and influence, in both political and personal spheres. The decisions these companies make about ethics are critically important, as they help determine what products are developed, how they are developed, how they are promoted, and potentially even how they are regulated. In the last fifteen years, for-profit private companies have been assembling bioethics committees to help resolve dilemmas that require informed deliberation about ethical, legal, scientific, and economic considerations. Private sector bioethics committees represent an important innovation in the governance of emerging technologies, with corporations taking a lead role in deciding what is ethically appropriate or problematic. And yet, we know very little about these committees, including their structures, memberships, mandates, authority, and impact. Drawing on an extensive literature review and qualitative analysis of semi-structured interviews with executives, scientists and board members, this dissertation provides an in-depth analysis of the Ethics and Public Policy Board at SmithKline Beecham, the Ethics Advisory Board at Advanced Cell Technology, and the Bioethics Committee at Eli Lilly and offers insights about how ideas of bioethics and governance are currently imagined and enacted within corporations. The SmithKline Beecham board was the first private sector bioethics committee; its mandate was to explore, in a comprehensive and balanced analysis, the ethics of macro trends in science and technology. The Advanced Cell Technology board was created to be like a watchdog for the company, to prevent them from making major errors. The Eli Lilly board is different than the others in that it is made up mostly of internal employees and does research ethics consultations within the company. These private sector bioethics committees evaluate and construct new boundaries between their private interests and the public values they claim to promote. Findings from this dissertation show that criticisms of private sector bioethics that focus narrowly on financial conflicts of interest and a lack of transparency obscure analysis of the ideas about governance (about expertise, credibility and authority) that emerge from these structures and hamper serious debate about the possible impacts of moving ethical deliberation from the public to the private sector.
ContributorsBrian, Jennifer (Author) / Robert, Jason S (Thesis advisor) / Maienschein, Jane (Committee member) / Hurlbut, James B (Committee member) / Sarewitz, Daniel (Committee member) / Brown, Mark B. (Committee member) / Moreno, Jonathan D. (Committee member) / Arizona State University (Publisher)
Created2012
136373-Thumbnail Image.png
Description
I will examine the relation between techne and virtue as it appears in Plato‘s dialogues and suggest that in order to adequately confront our greatest political and social challenges our understanding must move beyond mere scientific and technical knowledge and our practices must move beyond the political art taught by

I will examine the relation between techne and virtue as it appears in Plato‘s dialogues and suggest that in order to adequately confront our greatest political and social challenges our understanding must move beyond mere scientific and technical knowledge and our practices must move beyond the political art taught by Gorgias and Protagoras. It is my belief that the Platonic conception of virtue and the political art that aims toward that conception of virtue offer a paradigm that can help remedy today‘s arguably technocratic political condition. I begin this work by exploring the nature of techne as it was understood in ancient Greece, and arguing (contra Irwin) that Plato did not hold a technical conception of justice. Whereas each techne establishes an eidos (idea, form, blueprint) in advance, which can be clearly known and uniformly applied in each particular case, I argue that Plato‘s conception of justice leaves all substantive content to be filled out in each concrete situation, precluding the possibility of the anticipatory disposition that techne affords and demanding a certain degree of deliberation in each situation, with attention paid to the unique aspects of each particular set of circumstances. I argue that this conception of justice informs Plato's notion of a "political art" and suggest that this art requires constant attention to the unique attributes of each particular situation in which we find ourselves, and that the pre-interpretive prejudice of many modern ideologies and political-economic perspectives hinders our ability to see the particularity in each situation and thereby reduces our capacity for achieving justice in the historically-situated, concrete moment within which we always must act.
ContributorsOlsen, Tyler (Author) / Crittenden, Jack (Thesis director) / Ramsey, Ramsey Eric (Committee member) / Barrett, The Honors College (Contributor) / School of Historical, Philosophical and Religious Studies (Contributor) / School of Politics and Global Studies (Contributor)
Created2015-05
135520-Thumbnail Image.png
Description
With the help of some Information Measurement Theory (IMT), Kashiwagi Solutions Model (KSM), and deductive logic background, supply chain managers can start utilizing a new way to effectively and efficiently negotiate contracts. Developed by Dr. Dean Kashiwagi, the Best Value Approach has been 98% successful with over 1,800 projects for

With the help of some Information Measurement Theory (IMT), Kashiwagi Solutions Model (KSM), and deductive logic background, supply chain managers can start utilizing a new way to effectively and efficiently negotiate contracts. Developed by Dr. Dean Kashiwagi, the Best Value Approach has been 98% successful with over 1,800 projects for the past 20 years. The process gives vendors/suppliers the power to use their expertise. In return for not having to follow the rules set by the client/buyer, the vendor must show documentation and plans of risk management, value added processes, and metrics.
ContributorsPhan, Alice (Co-author) / Holtzman, Krista (Co-author) / Kashiwagi, Dean (Thesis director) / Kashiwagi, Jacob (Committee member) / School of International Letters and Cultures (Contributor) / Department of Supply Chain Management (Contributor) / Barrett, The Honors College (Contributor)
Created2016-05